BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 38378668)

  • 1. An angel or a devil? Current view on the role of CD8
    Peng Y; Yang H; Chen Q; Jin H; Xue YH; Du MQ; Liu S; Yao SY
    J Transl Med; 2024 Feb; 22(1):183. PubMed ID: 38378668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in multiple sclerosis and myasthenia gravis.
    Danikowski KM; Jayaraman S; Prabhakar BS
    J Neuroinflammation; 2017 Jun; 14(1):117. PubMed ID: 28599652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
    Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
    J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
    Aricha R; Reuveni D; Fuchs S; Souroujon MC
    J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.
    Yao X; Kong Q; Xie X; Wang J; Li N; Liu Y; Sun B; Li Y; Wang G; Li W; Qu S; Zhao H; Wang D; Liu X; Zhang Y; Mu L; Li H
    Immunology; 2014 Nov; 143(3):396-405. PubMed ID: 24850614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
    Xin N; Fu L; Shao Z; Guo M; Zhang X; Zhang Y; Dou C; Zheng S; Shen X; Yao Y; Wang J; Wang J; Cui G; Liu Y; Geng D; Xiao C; Zhang Z; Dong R
    Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis.
    Mu L; Sun B; Kong Q; Wang J; Wang G; Zhang S; Wang D; Liu Y; Liu Y; An H; Li H
    Immunology; 2009 Sep; 128(1 Suppl):e826-36. PubMed ID: 19740344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bakhiet M; van der Meide P; Wigzell H; Link H; Olsson T
    J Exp Med; 1996 Aug; 184(2):349-56. PubMed ID: 8760788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
    Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
    Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.
    Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL
    Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
    Wang CC; Zhang M; Li H; Li XL; Yue LT; Zhang P; Liu RT; Chen H; Li YB; Duan RS
    Neurosci Lett; 2017 Aug; 656():169-176. PubMed ID: 28743581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
    Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
    Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
    Feferman T; Maiti PK; Berrih-Aknin S; Bismuth J; Bidault J; Fuchs S; Souroujon MC
    J Immunol; 2005 May; 174(9):5324-31. PubMed ID: 15843529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of circulating CD4(+)CXCR5(+)FOXP3(+) Tfr-like cells and CD4(+)CXCR5(+)FOXP3(-) Tfh-like cells in myasthenia gravis.
    Wen Y; Yang B; Lu J; Zhang J; Yang H; Li J
    Neurosci Lett; 2016 Sep; 630():176-182. PubMed ID: 27473945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of memory T cells, follicular T cells and relevant cytokines in the peripheral blood of patients with myasthenia gravis during treatment].
    Ma L; Wu T; He J; Shen X; Yu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):257-262. PubMed ID: 35365992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.
    Huang H; Ran H; Liu X; Yu L; Qiu L; Lin Z; Ou C; Lu Y; Yang W; Liu W
    Int Immunopharmacol; 2021 Apr; 93():107434. PubMed ID: 33556668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.